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Fungi are an important part of the microbiota in healthy barrier
tissues. Fungal dysbiosis in turn is associated with local and
distal inflammatory diseases. Recent advances have shed light
on the antigen-specific IL-17-dependent mechanisms that
regulate fungal commensalism and prevent fungal overgrowth
during homeostasis. Progress in our understanding of species-
specific differences in fungus-host interactions provides new
hypotheses of why Candida albicans-targeting T cells exceed
those directed against other fungal species in the human T cell
repertoire. Importantly, C. albicans-specific Th17 cells can also
contribute to immune pathology in distant organs such as the
lung via cross-reaction with heterologous antigens.
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Introduction
The microbiota forms an essential component of human
body homeostasis and the direct microbiota-host interac-
tion at barrier tissues is a central regulatory knot affecting
many human diseases. Fungi are an integral, though
largely neglected part of the microbiota [1]. However,
recent data highlight certain fungal species as prototypic
examples for microbiota-mediated immune modulation
in humans. Fungi interact with the immune system via
molecular patterns triggering innate immune receptors.
However, due to sharing of those molecular patterns
between fungi, the contribution of individual species to
the overall antifungal response is not clear. Some com-
mensal fungi, including Aspergillus fumigatus, Candida
albicans and Malassezia spp. are potent inducers of
antigen-specific T cell responses, equally or even exceed-
ing that of bacterial or viral species [2]. Thus, they
represent prototypic examples to define the principles
of homeostatic immunity and how T cell responses
against commensals may impact on immune pathologies.
Here we focus on C. albicans and Malassezia spp. as
commensals of skin and mucosal tissues. The T cell
response against Aspergillus spp. as representative of
chronically encountered environmental fungi in the lung
is summarized in Ref. [3]. Here we discuss recent
advances in our understanding how fungal commensalism
is regulated by T helper cells and how normally host-
protective mechanisms directed against commensal fungi
can drive pathology and disease. We alsohighlight open
questions and challenges in the field.
Th17 mediated immunosurveillance of the
mycobiota at epithelial barriers
Constant exposure to commensal microbes results in a
continuous or repeated activation of the immune system
at barrier tissues but obviously at a subclinical level.
Active immune surveillance of the microbiota is critical
to prevent dysbiosis, microbial overgrowth and transloca-
tion across epithelial barriers. Besides essential innate
immune mechanisms, an active role for immune surveil-
lance at barrier sites has especially been demonstrated for
Th17 cells, and several Th17 inducing microbes have
been identified in mice [4–6] including C. albicans and
Malassezia spp. [7,8,9] (Figure 1). Interestingly, human
patients with genetic Th17 deficiencies suffer mainly
from mucocutaneous candidiasis [10] in contrast to
broader fungal susceptibilities of patients with innate
immune defects [11]. Consistently, C. albicans is a major
target of human Th17 responses [12,13]. Human Th17
responses also target other fungal species, especially
Malassezia spp. [2,8] and IL-17A blockade was linked
to Malassezia-associated pathology [14]. Anti-fungal T
cells develop into tissue-resident memory T (TRM) cells
[15,16] to locally shield epithelial barriers while high
frequencies commensal fungi-targeting memory T cells
also circulate in the blood [2,12]. C. albicans also induces
specific Foxp3+ regulatory T cell responses but numeri-
cally less than T effector cells [17,18]. Tregs may support
Th17 development by IL-2 deprivation [19], although in
a model for C. albicans commensalism, the depletion of
Tregs did not interfere with homeostatic Th17 immunity
or fungal colonization [20]. Thus, the functional role of
Tregs for the antigen-specific homeostatic balance is not
clear.
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Overall, only few microbial species, and in humans espe-
cially C. albicans induce strong Th17 responses indicative
of firm but balanced interactions with the immune system
and specialized properties to induce antigen-specific
Th17 immunity. Further, C. albicans may broadly modu-
late Th17 responses against other fungi via cross-reactiv-
ity to shared fungal epitopes ([2] and see below). Th17
cells have also been subdivided into ‘pathogenic’ versus
‘non-pathogenic’ Th17 cells, relating to their differential
function in human diseases [21], but their in vivo rele-
vance and potential induction pathways are unclear (see
Box 1). Therefore, it will be of major importance to define
the signals of Th17 cell differentiation, functional plas-
ticity and maintenance in relation to antigen-specificity,
in vivo priming conditions and the local tissue
environment.
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Figure 1
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Protective and pathological effects of commensal fungi-specific Th17 cells in the skin, the gut and the lung.
Top row: T helper cells provide antigen-specific protection against fungal commensals in the normal skin and gut. The dominance of Th17 cells
(green cells) directed against C. albicans (orange TCR) followed by Th17 cells directed against Malassezia (purple TCR) or any other commensal
fungi (grey TCR) in the human T cell repertoire is indicated by the number of plotted cells. A small proportion of fungus-specific Th1 and Th2 cells
(blue cells) can also be detected in humans. How Tregs modulate the Th17 response remains unclear (as indicated by a dotted arrow). IL-17
production in response to commensal fungi may regulate epithelial barrier integrity and/or antimicrobial peptide (AMP) production to promote
microbial homeostasis including the equilibrium between bacterial and fungal commensals. C. albicans-specific Th17 cells may modulate
neutrophil-mediated immunity against systemic infection with S. aureus. Bottom row: Predisposing conditions of the host, such as inflammation
and epithelial barrier disruption of the skin (atopic dermatitis (AD)) or the gut (inflammatory bowel disease, IBD), which are characterized by
microbial translocation, are associated with pathological effects of commensal fungi-specific Th17 cells (dark green cells), and Th2 cells (in case of
AD, purple cells). Serum amyloid A (SAA) is one factor proposed to regulate the functional plasticity of Th17 cells in the gut. Commensal
translocation may furthermore lead to the activation of Th17/Th1 cells that target translocated microbes and further exacerbate inflammation
(yellow TCR) via a hitherto unclear mode of action. Th17 cells primed against C. albicans may also act in distant tissues and cross-react against
other microbes, such as A. fumigatus in the inflamed lung (red TCR) to drive lung pathology (as in COPD, left side of the lung) or synergize with A.
fumigatus-specific non-cross-reactive Th2 cells in the allergic lung during ABPA (right side of the lung).
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Contribution of commensal fungi-specific
memory T cells to immune protection and
pathology
The microbiota has a broad beneficial or adverse impact
on human health, but the contribution of fungal species is
currently underappreciated. However, intestinal fungi,
similarly to bacterial microbes, can modulate the intesti-
nal balance [22] as well as the response to infections
[22,23] or allergy against distal heterologous antigens
[24–26] with an important contribution of C. albicans in
both, humans [27] and murine models [23,28,29] (Fig-
ure 1). C. albicans or Malassezia overgrowth is also associ-
ated with human IBD [26,30] and exacerbated experi-
mental colitis [30,31] and it may contribute to
inflammation in patients with alcoholic liver disease
[32,33]. Increased Candida colonization in allogeneic
hematopoietic stem cell transplant patients correlates
with the incidence of invasive candidiasis [34] and
severe GvHD [35,36]. On the contrary, reduction of
Candida colonization by faecal microbiota transplantation
in ulcerative colitis patients correlates with a better
disease outcome [37]. A role of Malassezia spp. in skin
[8] and lung [38] inflammation as well in carcinogenesis
[39,40] has been described.
Thus, fungi broadly modulate local as well as systemic
immune responses. However, the reported effects of
commensals are not antigen-specific or species-specific.
Most identified mechanisms so far include microbial
‘patterns’ including innate immune receptor ligands or
metabolites. Thus, it is currently an open question how
microbiota may modulate T cell-dependent, that is anti-
gen-specific effects. Acute gastrointestinal infections can
broadly modulate T cell reactivity against commensal
microbes [41]. However, the non-acute or ‘homeostatic’
response to commensals is dominated by antigen-specific
Th17 cells [2,12,23,42]. Thus, we will here focus on
those few fungi known to leave a specific footprint within
the T cell repertoire during host-microbiome interaction.
We discuss how specific antigen recognition may contrib-
ute to local or distal immune protection or pathology,
involving different types of target antigens and divers T
cell functionalities.
Local effect of commensal fungi on T cell mediated
immune homeostasis and inflammation
The strongest Th17 response in healthy humans known
so far is directed against C. albicans [2,12,17]. Candida-
specific Th17 cells seem to be non-pathogenic but essen-
tial to prevent C. albicans overgrowth without causing
overt inflammation (see Box 1). In murine colonization
models, intestinal [23] and oral [20] C. albicans induce a
non-inflammatory fungus-specific Th17 response. Intes-
tinal inflammation and damage may enhance antigen
accessibility since C. albicans-specific Th17 responses
are increased in the blood of IBD patients [2] and their
frequencies correlated with the fecal abundance of C.
albicans in intensive care unit patients [23]. However,
IL-17 blockade in IBD patients has been proven ineffec-
tive or even harmful, suggesting that Th17 responses
against Candida are not diseases-promoting, but rather
protective in the inflamed gut, presumably via strength-
ening barrier repair functions. Thus the positive associa-
tion between the intestinal abundance of Candida or
Malassezia [30,31] and more severe IBD may, therefore,
not primarily be mediated via IL-17, but via IL-17-
independent mechanisms. Whether fungus-specific T
cells contribute to IBD via acquisition of ‘pathogenic’
functions remains to be analyzed.
In the skin, Malassezia colonization induces Th17 cells
which control fungal growth in mice [8] but enhance the
inflammatory responses upon epithelial damage in an IL-
23 and IL-17-dependent manner [8]. Similarly, in
patients with atopic dermatitis increased Th17 responses
against Malassezia were observed [8,43]. Malassezia-
reactive T cells may contribute to AD pathogenesis via
cross-reactivity against conserved host proteins such as
thioredoxin and manganese-dependent superoxide dis-
mutase [43,44]. The relevance of IL-17 in disease patho-
genesis of AD is not clear but may be most relevant in
subtypes of the disease [45–47].
In psoriasis, the Th17 pathway plays a central pathogenic
role. Although the antigens stimulating local IL-17
release are not identified so far, members of the skin
microbiota or mycobiota are prime suspects. There are
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Box 1 Pathogenic Th17 cells: a matter of phenotype, location or
both.
T helper cell subsets display a certain degree of plasticity. The plasticity
concept integrates the possibility that certain lineages can adapt to
environmental signals and gradually shut down lineage-specific fea-
tures and instead co-express features of other lineages [74]. Plasticity
is particularly evident for Th17 and Treg cells. The concept of ‘
pathogenic’ and ‘non-pathogenic’ Th17 cells is largely based on in
vitro Th17 induction protocols using different cytokine combinations,
that is, IL-6, IL-1b and IL-23 versus IL-6 and TGF-b, respectively, and
their capacity to induce disease in murine models [75]. Th17 cells can
integrate different environmental signals and adapt functionality, as
recently described for serum amyloid proteins promoting pathogenic
Th17 cells locally in tissues during colitis and EAE [76]. Th17 plasticity
may also comprise acquisition of protective functions, as recently
described for commensal-specific Th17 cells in murine skin [77].
However, to which extent antigen-specific Th17 cells in humans are
subjected to such plasticity is not clear. Interestingly, the prototypic
Th17 cells targeting C. albicans and S. aureus phenotypically repre-
sent ‘pathogenic’ and ‘non-pathogenic’ Th17 subsets, respectively
[78,79], despite the fact that both microbes do not normally cause
pathology. It is also not clear if the C. albicans-specific fraction of Th17
cells cross-reactive to A. fumigatus in human lung may be pathogenic
due to functional alterations or simply due to location and target
specificity, that is, lung versus intestine or skin [2]. Further work is
required to determine how antigen-specificity, tissue site and envir-
onmental cues including inflammatory signals shape human Th17
functional plasticity [80].
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variable reports on the composition of the microbiome
and mycobiome in psoriatic skin [48] with Malassezia and
Staphylococcus among the most frequent genera. Whether
specific T cell and Th17 reactivity against these microbes
are altered and causatively linked to disease in humans
remains unclear [48]. In support of this idea, re-activation
of commensal-specific Th17 cells can aggravate tissue
inflammation in an experimental model of psoriasis [49].
Moreover, the increased incidence of C. albicans infec-
tions in psoriasis patients treated with IL-17-targetting
antibodies [50,51] indicates that interfering with the IL-
17 response can modulate the mycobiota.
Systemic effects of commensal fungi on immune
homeostasis and inflammation
Although it is known that the intestinal microbiota
including the mycobiota affect immune responses at a
distance, very little is known how fungus-specific T cells
contribute to this process. C. albicans Th17 cells protect
against systemic infection with unrelated pathogens and
exacerbate lung allergy presumably via IL-17-mediated
systemic neutrophil activation [23]. This may involve T
cell receptor-independent bystander activation [52,53].
However, it is becoming increasingly clear that cross-
reactivity to commensal fungi affects systemic immune
responses (see Box 2). Surprisingly, the majority of human
fungus-specific Th17 cells, were shown to be cross-reac-
tive against C. albicans, most likely via recognition of
homologous epitopes [2]. This suggests that human
anti-fungal Th17 responses rely on cross-reactivity
against C. albicans as a major direct Th17 inducer. Overall
increased target diversity may broaden the Th17 protec-
tive function but may also enhance pathology. Indeed,
cross-reactive Th17 cells reacting against Aspergillus
expand and are recruited to the lung of patients with
allergic bronchopulmonary aspergillosis [2]. Impor-
tantly, these cross-reactive Th17 cells were not obviously
functionally distinct from non-cross-reactive Th17 cells,
suggesting that the decision between pathogenic and
non-pathogenic may depend on the local tissue environ-
ment and the target antigen.
Mechanistic aspects of commensal fungi-
specific T cell immunity
C. albicans-reactive T cells in humans exceed those
directed against other commensal or environmental fungi
[2] but the underlying cause remains unclear. Possible
factors include differences in Th17-inducing PAMP
exposure, in the expression of immune dominant and/
or cross-reactive antigens and in tissue invasiveness, as we
will discuss in the following section.
The Th17 polarizing cytokines IL-6, IL-1 and IL-23, are
induced efficiently by fungal cell wall carbohydrates via
Dectin-1, Dectin-2 or Mincle triggering the Syk/Card9
pathway [54]. The ligands are highly conserved across
fungi but their exposure varies significantly due to vari-
ability in the cell wall architecture of different fungal
species [55], which may be further modulated by envi-
ronmental factors [56]. Taking into account this, C. albi-
cans can be predicted to be among the strong inducers.
However, experimental infection models demonstrate a
strong Th17 inducing capacity of many other fungi,
including Malassezia spp. [8], Aspergillus [57], dermato-
phytes [58] and the dimorphic fungi [59]. Thus, innate
receptor activation alone unlikely explains the superior
Th17 inducing capacity of C. albicans in humans.
An alternative explanation for the prevalence of C. albi-
cans-specific Th17 cells may be the availability of C.
albicans-derived antigens early in life and/or specific
characteristics of the antigens. C. albicans is found in
the gastrointestinal tract shortly after birth [60] and also
on the skin of children [61] and neonatal T cells effi-
ciently respond to C. albicans [62]. In contrast, Malassezia
reaches broad colonization of the skin only during puberty
[63]. An early pool of C. albicans-specific Th17 cells may
provide a source for recruitment of cross-reacting Th17
cells against other species and at the same time prevent-
ing de novo Th17 induction by other antigens. So far, only
a small number of naturally processed and presented C.
albicans-derived T cell antigens have been identified,
some of which are conserved between even distantly
related fungi [2,64]. The recognition of shared epitopes
provides an explanation for the cross-reactivity of C.
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Box 2 Microbiota and TCR cross-reactivity in the human
immune system.
Cross-reactivity, that is, recognition of two peptides, related or
unrelated, by the same TCR, is often regarded as a rare phenomenon
in immunology. However, its impact, mainly on virus-specific CD8+ T
cells has been well documented [81]. In fact, TCRs need to cross-
react for providing comprehensive immune coverage and they
indeed recognize multiple and even unrelated epitopes [82,83].
Humans also accumulate a highly divers memory TCR repertoire
since they encounter many different antigens throughout life. Thus,
neo-antigens can be recognized by memory as well as naı̈ve T cells
[13,84–86]. Other examples include microbe-specific memory T cells
with cross-reactivity against other microbes [87], autoantigens [88] or
allergens [81]. Furthermore, T cells involved in lung autoimmunity
were found to express dual TCRs recognizing an intestinal com-
mensal and an autoantigen, respectively [89]. We are only beginning
to understand the diverse consequences of such cross-reactive T
cells on antigen-specific immunity in infections, vaccination, auto-
immune disease or allergies [81,83,88]. The commensal microbiota
represents an enormous source of antigens, it can be expected to
engage a significant fraction of the human T cell repertoire [90] and
shape antigen-specific immunity. The broad modulation of human
anti-fungal Th17 responses by the commensal fungus C. albicans
discussed herein [2] seems to be a particularly relevant example.
However, cross-reactivity to microbiota in general provides a rational
antigen-specific immune modulation by the microbiota. Therefore, it
will be of utmost importance to resolve human immune protection
and pathology on the level of antigen-specificity and to correlate
specificity and potential cross-reactivity with functional activity, that
is, protection versus pathogenicity.
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albicans-induced T cells [2], although it remains to be
proven whether cross-reactivity is indeed mediated anti-
gen-specifically. Identifying the targeted epitopes, espe-
cially those targeted by Th17 cells, will be a key step in
the future. It will also be interesting to determine
whether T cells primed by fungi other than C. albicans
can also exert cross-reactivity, and thus whether this
represents a more general principle. Overall, mounting
cross-reactive T cell populations against distinct micro-
bial species may allow saving resources by sharing reac-
tivity, which represents an advantage for the host but
entail a risk for pathological consequences.
Adherence to the epithelia has been demonstrated to be a
critical feature of murine Th17-inducing microbes,
including C. albicans [6]. The potential of C. albicans to
firmly interact with and invade epithelia exceeds that of
other fungal commensals. Tissue damage by C. albicans
triggers inflammation and epithelial invasion via the
recently identified peptide toxin candidalysin, which
promotes epithelial damage [65], epithelial translocation
[66] and the release of Th17-triggering cytokines
[67,68]. This has mainly been demonstrated by in vitro
cultures and experimental models of acute primary infec-
tion characterized by inflammation and IL-17 production
by innate lymphocytes [69,70]. Importantly, however,
antigen-specific Th17 immunity is induced upon C. albi-
cans colonization in the absence of inflammation and
independently of strain virulence [71]. Also, all humans
mount a C. albicans-specific Th17 cell response [2,12]
irrespective of the colonizing fungal strain. Thus, C.
albicans colonization may provide a Th17 trigger without
overt inflammation, thereby enabling peaceful coexis-
tence. Interestingly C. albicans maintains its virulence
only during co-colonization with bacterial microbiota
suggesting an evolutionary benefit [72]. Thus, it might
be speculated that low-level invasion and Th17 induction
provides a positive feedback loop creating a niche for C.
albicans survival in a competitive intestinal environment.
It will be important to set up suitable mouse models
mimicking the chronic exposure to commensal fungi to
decipher the relevant molecular details of Th17
induction.
Concluding remarks and future challenges
Immune protection and immune mediated diseases are
highly antigen-specific processes, and it is a major gap in
our understanding how microbiota modulates function-
ally diverse antigen-specific T cell responses contributing
to health and disease. Commensal fungi play a pivotal but
so far understudied role in this process. Despite their low
abundance within the microbiota, fungi have emerged as
potent inducers of antigen-specific T cell in humans,
controlling homeostatic host-fungus interactions and con-
tributing to immune pathology if dysregulated, as dis-
cussed herein for Th17 cells. These studies also highlight
that cross-reactivity to microbiota is common within
human T cell immunity and represents a neglected
aspect of immune modulation, which has to be addressed
in the future. However, there remain several open ques-
tions: Which members of the mycobiota or microbiota
actively induce adaptive human immune responses and
what regulates the balance between antigen-specific
effector and regulatory T cell subsets? What defines
phenotypic and functional features of protective and
pathogenic Th17 cells, including the relation between
tissue-resident and circulating T cells: antigen-specificity
or tissue context? Comprehensive answers to these ques-
tions will depend on a combination of studies in humans
and closely adapted model systems. Choosing relevant
human-like models to adequately mirror homeostatic
fungus-host interactions is critical with respect to fungal
strain [71], complexity of the host microbiota [73], dura-
tion and intensity of exposure, and antigen-specificity of
the readouts.
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